BTK and autoimmune thrombocytopenic purpura: BTK inhibition also led to positive outcomes in some other autoimmune diseases, including urticaria (NCT03137069), immune thrombocytopenia (ITP) (NCT04562766), pemphigus (NCT03762265), and IgG4-related disease (RD) (NCT04520451).